EA199800275A1 - Альтернативная кристаллическая форма тазофелона - Google Patents
Альтернативная кристаллическая форма тазофелонаInfo
- Publication number
- EA199800275A1 EA199800275A1 EA199800275A EA199800275A EA199800275A1 EA 199800275 A1 EA199800275 A1 EA 199800275A1 EA 199800275 A EA199800275 A EA 199800275A EA 199800275 A EA199800275 A EA 199800275A EA 199800275 A1 EA199800275 A1 EA 199800275A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- tasophelon
- crystal form
- alternative crystal
- tazofelon
- thiazolidinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Abstract
Настоящее изобретение обеспечивает новую кристаллическую Форму II (±)-5-{[3,5-бис-(1,1-диметилэтил)-4-гидроксифенил]метил}-4-тиазолидинона, имеющую картину порошковой дифракции рентгеновских лучей с межплоскостным расстоянием d 5,64, 5,16, 4,90, 4,66 и 4,49A, которая применяется для лечения воспалений, воспалительных заболеваний кишечника, аллергий, артрита и гипогликемии при употреблении новой физической формы в качестве фармацевтической композиции, содержащей ее. Описывается также способ получения Формы II тазофелона.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US335695P | 1995-09-07 | 1995-09-07 | |
| PCT/US1996/014132 WO1997009320A1 (en) | 1995-09-07 | 1996-09-03 | Alternate crystal form of tazofelone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA199800275A1 true EA199800275A1 (ru) | 1998-08-27 |
| EA000258B1 EA000258B1 (ru) | 1999-02-25 |
Family
ID=21705475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA199800275A EA000258B1 (ru) | 1995-09-07 | 1996-09-03 | Альтернативная кристаллическая форма тазофелона |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0761656B1 (ru) |
| JP (1) | JPH11514978A (ru) |
| KR (1) | KR19990044453A (ru) |
| CN (1) | CN1082958C (ru) |
| AR (2) | AR003484A1 (ru) |
| AT (1) | ATE198476T1 (ru) |
| AU (1) | AU716684B2 (ru) |
| BR (1) | BR9610201A (ru) |
| CA (1) | CA2231132A1 (ru) |
| CO (1) | CO4750653A1 (ru) |
| CZ (1) | CZ68098A3 (ru) |
| DE (1) | DE69611407T2 (ru) |
| DK (1) | DK0761656T3 (ru) |
| EA (1) | EA000258B1 (ru) |
| ES (1) | ES2153081T3 (ru) |
| GR (1) | GR3035656T3 (ru) |
| HU (1) | HUP9901458A3 (ru) |
| IN (1) | IN182320B (ru) |
| MY (1) | MY132351A (ru) |
| NO (1) | NO309719B1 (ru) |
| NZ (1) | NZ316810A (ru) |
| PE (1) | PE23298A1 (ru) |
| PL (1) | PL325602A1 (ru) |
| PT (1) | PT761656E (ru) |
| SI (1) | SI0761656T1 (ru) |
| TR (1) | TR199800398T1 (ru) |
| TW (1) | TW460471B (ru) |
| WO (1) | WO1997009320A1 (ru) |
| ZA (1) | ZA967422B (ru) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US538690A (en) * | 1895-05-07 | Automatic watering-trough for animals | ||
| ZA9010041B (en) * | 1989-12-21 | 1992-08-26 | Lilly Co Eli | Compounds for treating inflammatory bowel disease |
| US5216002A (en) * | 1989-12-21 | 1993-06-01 | Eli Lilly And Company | Method of treating inflammatory bowel disease |
-
1996
- 1996-09-02 ZA ZA9607422A patent/ZA967422B/xx unknown
- 1996-09-02 AR ARP960104199A patent/AR003484A1/es not_active Application Discontinuation
- 1996-09-02 TW TW085110670A patent/TW460471B/zh active
- 1996-09-02 IN IN1563CA1996 patent/IN182320B/en unknown
- 1996-09-02 AR ARP960104198A patent/AR003483A1/es not_active Application Discontinuation
- 1996-09-02 ES ES96306336T patent/ES2153081T3/es not_active Expired - Lifetime
- 1996-09-02 PE PE1996000641A patent/PE23298A1/es not_active Application Discontinuation
- 1996-09-02 EP EP96306336A patent/EP0761656B1/en not_active Expired - Lifetime
- 1996-09-02 PT PT96306336T patent/PT761656E/pt unknown
- 1996-09-02 DE DE69611407T patent/DE69611407T2/de not_active Expired - Fee Related
- 1996-09-02 SI SI9630287T patent/SI0761656T1/xx unknown
- 1996-09-02 AT AT96306336T patent/ATE198476T1/de not_active IP Right Cessation
- 1996-09-02 DK DK96306336T patent/DK0761656T3/da active
- 1996-09-03 BR BR9610201A patent/BR9610201A/pt not_active Application Discontinuation
- 1996-09-03 TR TR1998/00398T patent/TR199800398T1/xx unknown
- 1996-09-03 WO PCT/US1996/014132 patent/WO1997009320A1/en not_active Application Discontinuation
- 1996-09-03 PL PL96325602A patent/PL325602A1/xx unknown
- 1996-09-03 KR KR1019980701701A patent/KR19990044453A/ko not_active Application Discontinuation
- 1996-09-03 EA EA199800275A patent/EA000258B1/ru not_active IP Right Cessation
- 1996-09-03 AU AU69127/96A patent/AU716684B2/en not_active Ceased
- 1996-09-03 CA CA002231132A patent/CA2231132A1/en not_active Abandoned
- 1996-09-03 JP JP9511339A patent/JPH11514978A/ja active Pending
- 1996-09-03 HU HU9901458A patent/HUP9901458A3/hu unknown
- 1996-09-03 NZ NZ316810A patent/NZ316810A/xx unknown
- 1996-09-03 CN CN96197822A patent/CN1082958C/zh not_active Expired - Fee Related
- 1996-09-03 CZ CZ98680A patent/CZ68098A3/cs unknown
- 1996-09-04 MY MYPI96003663A patent/MY132351A/en unknown
- 1996-09-05 CO CO96047346A patent/CO4750653A1/es unknown
-
1998
- 1998-03-03 NO NO980913A patent/NO309719B1/no not_active IP Right Cessation
-
2001
- 2001-03-29 GR GR20010400506T patent/GR3035656T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1007017E (pt) | Nova formulacao para inalacao possuindo uma massa volumica aparente de 0,28 a 0,38 g/ml, um processo para a sua preparacao formulacao e sua utilizacao | |
| NO965298L (no) | Ny krystallmodifikasjon av CDCH, fremgangsmåte for fremstilling derav og farmasöytiske preparater inneholdende denne | |
| AU6905391A (en) | Methods and compositions for the treatment of hodgkin's disease | |
| EA200000711A1 (ru) | 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, СПОСОБ ПОЛУЧЕНИЯ ФАРМАЦЕВТИЧЕСКИХ ПРЕПАРАТОВ, СОДЕРЖАЩИХ ЭТИ 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, И ИХ ПРИМЕНЕНИЕ ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ | |
| AU588837B2 (en) | Polypeptide | |
| MY117090A (en) | Substituted benzamidines, their preparation and their use as pharmaceutical compounds | |
| DE59002863D1 (de) | Lysolecithinderivate zur behandlung von autoimmunerkrankungen. | |
| BR8901248A (pt) | Triazois substituidos,processo para sua preparacao,composicoes herbicidas,processos para combater ervas daninhas e para preparacao de composicoes e compostos | |
| BR8801149A (pt) | "2,5-dihidropirrois,processo para sua preparacao,composicoes herbicidas,processos para combater ervas daninhas e para a preparacao de composicoes,compostos e processo para sua preparacao | |
| EA199800275A1 (ru) | Альтернативная кристаллическая форма тазофелона | |
| AU617036B2 (en) | Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom | |
| RO80320A (ro) | Procedeu de preparare a unui compozitii insecticide si nematocide | |
| ES2128313T3 (es) | Naftalimidas n-substituidas, su obtencion y empleo. | |
| IL77051A (en) | Crystalline form of the monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide and pharmaceutical compositions containing it | |
| FR2426665A1 (fr) | Hydrocarbures halogenes utiles notamment comme composes intermediaires pour pesticides et leur procede de production | |
| IT1144772B (it) | Procedimento per la preparazione di fertilizzanti pregiati e sottoprodotti utili | |
| IT1129805B (it) | Composti dell'1 4 diossaspiro 4 5 de cene particolarmente utili come in termedi per la preparazione di beta bloccanti clinici | |
| PT67391B (fr) | Methode de preparation d'une formulation insecticide et anti-parasitaire contenant du dimethylformamide comme synergisant et ameliorant des pyrethrines-pyrethrinoides et rotenones naturelles et de synthese | |
| JPS53144570A (en) | 1-osoindolinone derivatives and agriculture and horticulture containing the same as active constituents | |
| IT1145433B (it) | Composizione farmaceutiche impiegabili per il trattamento dell'ipertensione | |
| BR8206677A (pt) | Processo para a preparacao de alquilcicloalquil-imidazolil-meril-cetonas e aplicacao | |
| NO177706C (no) | Forbedret fremgangsmåte for fremstilling av trans-6-[2- (substituert-pyrrol-yl) alkylÅ pyran-2-on-inhibitorer for kolesterolsyntese | |
| KR950012913U (ko) | 담수직파기의 파종골다짐판 | |
| MA21396A1 (fr) | Procede de preparation d'un produit destine a reconstituer les cheveux ainsi que pour stimuler et augmenter leur croissance et produit ainsi obtenu. | |
| EP0014807A3 (en) | Synthesis of boroxarophenanthrenes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |